Formulation, optimization, and characterization of whey protein isolate nanocrystals for celecoxib delivery

References

• Ahuja, B.K., et al., 2015. Formulation, optimization and in vitro–in vivo evaluation of febuxostat nanosuspension. International journal of pharmaceutics, 478 (2), 540–552.
   PubMed Web of Science ®Google Scholar
• Ain-Ai, A. and Gupta, P.K., 2008. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound. International journal of pharmaceutics, 351 (1–2), 282–288.
   PubMed Web of Science ®Google Scholar
• Augustin, M.A. and Hemar, Y., 2009. Nano- and micro-structured assemblies for encapsulation of food ingredients. Chemical society reviews, 38 (4), 902–912.
   PubMed Web of Science ®Google Scholar
• Bijman, M.N., et al., 2008. Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels. Biochemical pharmacology, 75 (2), 427–437.
   PubMed Web of Science ®Google Scholar
• Bitterlich, A., et al., 2015. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling. European journal of pharmaceutics and biopharmaceutics, 92, 171–179.
   PubMed Web of Science ®Google Scholar
• Bose, S., et al., 2012. Application of spray granulation for conversion of a nanosuspension into a dry powder form. European journal of pharmaceutical sciences, 47 (1), 35–43.
   PubMed Web of Science ®Google Scholar
• Choi, J.S., Ahn, J.B., and Park, J.S., 2019. Amorphous multi-system of celecoxib improves its anti-inflammatory activity in vitro and oral absorption in rats. International journal of pharmaceutics, 555, 135–145.
   PubMed Web of Science ®Google Scholar
• Choi, J.S., et al., 2020. Therapeutic effects of celecoxib polymeric systems in rat models of inflammation and adjuvant-induced rheumatoid arthritis. Materials science and engineering, 114, 111042.
   Google Scholar
• Danhier, F., Feron, O., and Préat, V., 2010. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. Journal of controlled release, 148 (2), 135–146.
   PubMed Web of Science ®Google Scholar
• Esfanjani, A.F. and Jafari, S.M., 2016. Biopolymer nanoparticles and natural nanocarriers for nano-encapsulation of phenolic compounds. Colloids and surfaces B: biointerfaces, 146, 532–543.
   PubMed Web of Science ®Google Scholar
• Fan, Y., et al., 2020. Fabrication of pea protein nanoparticles with calcium-induced cross-linking for the stabilization and delivery of antioxidative resveratrol. International journal of biological macromolecules, 152, 189–198.
   PubMed Web of Science ®Google Scholar
• Farooq, M.A., et al., 2019. Whey protein: a functional and promising material for drug delivery systems recent developments and future prospects. Polymers for advanced technologies, 30 (9), 2183–2191.
   Web of Science ®Google Scholar
• Farooq, M.A., et al., 2020. Denatured food protein-coated nanosuspension: a promising approach for anticancer delivery of hydrophobic drug. Journal of molecular liquids, 303, 112690.
   Web of Science ®Google Scholar
• Farooq, M.A., et al., 2020. Globular protein stabilized nanoparticles for delivery of disulfiram: fabrication, characterization, in vitro toxicity, and cellular uptake. RSC advances, 10 (1), 133–144.
   Web of Science ®Google Scholar
• Fu, Q., et al., 2020. Preparation and in vitro antitumor effects on MDA-MB-231 cells of niclosamide nanocrystals stabilized by poloxamer188 and PBS. International journal of pharmaceutics, 584, 119432.
   PubMed Web of Science ®Google Scholar
• Gao, L., et al., 2013. Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs. Pharmaceutical research, 30 (2), 307–324.
   PubMed Web of Science ®Google Scholar
• Guo, M., et al., 2019. Impacts of particle shapes on the oral delivery of drug nanocrystals: mucus permeation, transepithelial transport and bioavailability. Journal of controlled release, 307, 64–75.
   PubMed Web of Science ®Google Scholar
• He, W., et al., 2013. Formulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: physical characterization, redispersibility, and dissolution. International journal of nanomedicine, 8, 3119.
   PubMed Web of Science ®Google Scholar
• He, Y., et al., 2020. Size effect of curcumin nanocrystals on dissolution, airway mucosa penetration, lung tissue distribution and absorption by pulmonary delivery. Colloids and surfaces. B, biointerfaces, 186, 110703.
   PubMed Web of Science ®Google Scholar
• Homayouni, A., et al., 2014. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP. European journal of pharmaceutics and biopharmaceutics, 88 (1), 261–274.
   PubMed Web of Science ®Google Scholar
• Hsiao, P.W., et al., 2007. Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells. Toxicology and applied pharmacology, 222 (1), 97–104.
   PubMed Web of Science ®Google Scholar
• Huang, Z.G., et al., 2019. RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability. International journal of pharmaceutics, 556, 217–225.
   PubMed Web of Science ®Google Scholar
• Junyaprasert, V.B. and Morakul, B., 2015. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian journal of pharmaceutical sciences, 10 (1), 13–23.
   Web of Science ®Google Scholar
• Li, Y., et al., 2015. Globular protein-coated paclitaxel nanosuspensions: interaction mechanism, direct cytosolic delivery, and significant improvement in pharmacokinetics. Molecular pharmaceutics, 12 (5), 1485–1500.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2020. Highly stabilized nanocrystals delivering Ginkgolide B in protecting against the Parkinson's disease. International journal of pharmaceutics, 577, 119053.
   PubMed Web of Science ®Google Scholar
• Lu, Y., Li, Y., and Wu, W., 2016. Injected nanocrystals for targeted drug delivery. Acta pharmaceutica sinica. B, 6 (2), 106–113.
   PubMed Web of Science ®Google Scholar
• Mohammadian, M., et al., 2019. Enhancing the aqueous solubility of curcumin at acidic condition through the complexation with whey protein nanofibrils. Food hydrocolloids, 87, 902–914.
   Web of Science ®Google Scholar
• Müller, R.H., Gohla, S., and Keck, C.M., 2011. State of the art of nanocrystals-special features, production, nanotoxicology aspects and intracellular delivery. European journal of pharmaceutics and biopharmaceutics, 78 (1), 1–9.
   PubMed Web of Science ®Google Scholar
• Owonubi, S.J., et al., 2018. Characterization and in vitro release kinetics of antimalarials from whey protein-based hydrogel biocomposites. IJIC, 9 (1), 39–52.
   Google Scholar
• Rosenholm, J.M., et al., 2009. Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems. Nano letters, 9 (9), 3011–3308.
   Web of Science ®Google Scholar
• Shen, X.C., et al., 2007. Spectroscopic studies on the interaction between human hemoglobin and CdS quantum dots. Journal of colloid and interface science, 311 (2), 400–406.
   PubMed Web of Science ®Google Scholar
• Shishir, M.R.I., et al., 2018. Advances in micro and nano-encapsulation of bioactive compounds using biopolymer and lipid-based transporters. Trends in food science & technology, 78, 34–60.
   Web of Science ®Google Scholar
• Singh, S.K., et al., 2011. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide. European journal of pharmaceutics and biopharmaceutics, 78 (3), 441–446.
   PubMed Web of Science ®Google Scholar
• Soisuwan, S., et al., 2019. Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals. European journal of pharmaceutics and biopharmaceutics, 137, 68–76.
   PubMed Web of Science ®Google Scholar
• Sun, J., et al., 2020. Tuning mPEG-PLA/vitamin E-TPGS-based mixed micelles for combined celecoxib/honokiol therapy for breast cancer. European journal of pharmaceutical sciences, 146, 105277.
   PubMed Web of Science ®Google Scholar
• Turánek, J., et al., 2009. Liposomal formulation of alpha-tocopheryl maleamide: in vitro and in vivo toxicological profile and anticancer effect against spontaneous breast carcinomas in mice. Toxicology and applied pharmacology, 237 (3), 249–257.
   PubMed Web of Science ®Google Scholar
• Wang, R., et al., 2019. Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity. Colloids and surfaces. B, biointerfaces, 174, 270–279.
   PubMed Web of Science ®Google Scholar
• Xia, D., et al., 2010. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. European journal of pharmaceutics and biopharmaceutics, 40, 325–334.
   Google Scholar
• Xie, Z., Zhang, Z., and Lv, H., 2019. Rapamycin loaded TPGS-Lecithins-Zein nanoparticles based on core-shell structure for oral drug administration. International journal of pharmaceutics, 568, 118529.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2017. Denatured protein-coated docetaxel nanoparticles: alterable drug state and cytosolic delivery. International journal of pharmaceutics, 523 (1), 1–14.
   PubMed Web of Science ®Google Scholar
• Zuo, J., et al., 2020. Design space approach in the development of esculetin nanocrystals by a small-scale wet-bead milling process. Journal of drug delivery science and technology, 55, 101486.
   Web of Science ®Google Scholar